ARCHIVES

Taxol Approved By FDA For Ovarian Cancer; Bristol Sets Price Tier In Line With Platinum

This article is from The Cancer Letter archive.

Vol. 19 No. 02 | January 8, 1993

Download PDF Visit The Full Archive

Related Articles

Garb’s Fight Now A Personal One

March 20, 1981

BSA, BSC Approve Concept for NCI Scholars Program

March 7, 1997

Spending Freeze Could Harm Medical Research, ACS Advocacy Affiliate Says

January 29, 2010

NCI T Phase Out Support Of VA Lung Group, But Will Continue Funding VASAG

November 3, 1978

Congressional Report Days NCI Ignored Data, Procedure, In Changes To Screening Guidelines

November 4, 1994

Zerhouni Starts Work As NIH Director

May 24, 2002